Skip to main content
logo
Merck KGaA (ETR:MRK)
Germany flag Germany · Delayed Price · Currency is EUR
143.15
+0.30 (0.21%)
Jul 31, 2026, 5:35 PM CET

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Process Solutions Revenue
3.88B3.79B3.52B
Life Science Services Revenue
--721.80M
Science & Lab Solutions Revenue
--4.67B
Oncology Revenue
1.88B1.93B2.01B
Neurology & Immunology Revenue
1.60B1.66B1.69B
Fertility Revenue
1.42B1.46B1.53B
Cardiovascular, Metabolism and Endocrinology Revenue
3.03B3.05B2.95B
Other Healthcare Revenue
328.40M328.00M280.50M
Surface Solutions Revenue
--406.50M
Semiconductor Solutions Revenue
2.49B2.50B2.63B
Advanced Solutions Revenue
2.35B2.37B-
Discovery Solutions Revenue
2.80B2.83B-
Total Life Science Revenue
9.03B8.98B8.92B
Rare Diseases Revenue
-188.20M-
Total Healthcare Revenue
8.54B8.61B8.45B
Optronics Revenue
753.50M774.20M748.30M
Total Electronics Revenue
3.38B3.51B3.79B
Revenue (Total)
20.96B21.10B21.16B

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Europe Revenue
6.46B6.42B6.17B
North America Revenue
5.46B5.52B5.71B
Asia Pacific Revenue
6.87B6.94B7.02B
Latin America Revenue
1.44B1.45B1.48B
Middle East & Africa Revenue
732.20M784.60M781.20M
Revenue (Other)
-100.00K100.00K300.00K
Revenue (Total)
20.96B21.10B21.16B

EBITDA

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Life Science EBITDA
2.61B2.59B2.59B
Healthcare EBITDA
3.00B3.08B2.99B
Electronics EBITDA
870.40M832.60M969.60M
Corporate/Others EBITDA
-379.90M-388.30M-481.80M
Operating Income (Other)
-2.57B-2.51B-2.43B
Operating Income (Total)
3.53B3.60B3.65B